dsdsa

product

Reasonable price Docetaxel Trihydrate - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

We insist on offering premium quality creation with very good company concept, honest product sales along with the finest and fast assistance. it will bring you not only the premium quality item and huge profit, but the most significant is to occupy the endless market for Lorcaserin, Ledipasvir-Co-Povidone, Docetaxel Powder, We're self-assured to create wonderful achievements while in the potential. We've been hunting forward to becoming one of your most trustworthy suppliers.
Reasonable price Docetaxel Trihydrate - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai Detail:

Product name Cabazitaxel
Synonyms (αR,βS)-β-[[(1,1-DiMethylethoxy)carbonyl]aMino]-α-hydroxybenzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-diMethoxy-4a,8,13,13-tetraMethyl-5-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
CAS No. 183133-96-2
Appearance White to almost white crystalline solid
Molecular Formula C45H57NO14
Molecular Weight 835.93
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Cabazitaxel CAS:183133-96-2

ITEMS STANDARDS RESULTS
CHARACTERISTICS White to almost white crystalline solid White crystalline solid
IDENTIFICATION Should to positive Positive
SOUBILITY Freely soluble in Acetone and Dichloromethane,Soluble in Ethanol and Methanol, Sparingly soluble in Ethyl acetate. Complies
LOSS ON DRYING ≤1.0% 0.1%
RESIDUE ON IGNITION ≤0.2% 0.05%
HEAVY METALS ≤20ppm Complies
RELATIVE SUBSTANCE Single impurity:≤0.3% 0.08%
Total Impurities:≤0.8 % 0.19%
RESIDUAL SOLVENT Tetrahydrofuran:≤0.072%Methanol: ≤0.3%

Dichloromethane:≤0.06%

Ethyl Acetate: ≤0.5%

Not DetectedNot Detected

Not Detected

Not Detected

ASSAY NLT 98.5% 99.78%
Conclusion:It complies to prescribed enterprise standard

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Reasonable price Docetaxel Trihydrate - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

Reasonable price Docetaxel Trihydrate - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures

Reasonable price Docetaxel Trihydrate - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai detail pictures


Related Product Guide:

Sticking for the perception of "Creating goods of high quality and making good friends with people today from all around the world", we constantly set the interest of shoppers to begin with for Reasonable price Docetaxel Trihydrate - High Purity USP EP 183133-96-2 Cabazitaxel for Anti-cancer Treatment – Yibai , The product will supply to all over the world, such as: Indonesia, Bogota, Buenos Aires, Why we can do these? Because: A, We are honest and reliable. Our items have high quality, attractive price, sufficient supply capacity and perfect service. B, Our geographical position has a big advantage . C, Various types: Welcome your inquiry, It might be highly appreciated.
  • The company leader recept us warmly, through a meticulous and thorough discussion, we signed a purchase order. Hope to cooperate smoothly
    5 Stars By Alexander from Ecuador - 2017.04.28 15:45
    Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
    5 Stars By Chris Fountas from French - 2018.10.09 19:07
    Write your message here and send it to us